Edgen Stock·Dec 13 2025, 06:45Back
ImmunityBio Drug Secures Key EU Panel Recommendation
Edgen Stock·Dec 13 2025, 06:45
[1] Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 December 2025 - European Medicines Agency (https://www.ema.europa.eu/en/news/meeting-hig ...)[2] Quebec becomes first province in Canada to list new subcutaneous OPDIVO® on public drug plan for solid tumour indications - BioSpace (https://www.biospace.com/press-releases/quebe ...)[3] Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants - BioSpace (https://www.biospace.com/press-releases/anixa ...)
